Real-world study looks at anticoagulant adherence

A new study confirms how poorly Australian patients stick to warfarin therapy, with 62% of those with atrial fibrillation (AF) abandoning medication after less than a year.

Warfarin patients are 2.5 times more likely to stop therapy over 12 months compared with those on non-vitamin-K oral anticoagulants (NOACs), the research shows.

“Persistence with NOAC drugs in patients with AF appears to be highly superior to warfarin,”